Biroida 5 mg Tablet
PDF Leaflet Revision Date: 25 July 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Management of hyperthyroidism and preparation for thyroidectomy.
Dosage (summary)
10 mg to 60 mg daily, titrated based on thyroid function.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Use lowest effective dose in pregnancy; contraindicated in breastfeeding.
Key Drug Interactions
- Increased effect of anticoagulants
- Increased theophylline levels
- Reduced clearance of erythromycin
Contraindications
- Hypersensitivity to carbimazole
- Severe hepatic insufficiency
- History of acute pancreatitis
Common side effects
- Nausea
- Headache
- Gastrointestinal disturbances
- Skin rashes
Counselling Points
- Monitor thyroid function regularly
- Report sore throat or bruising
- Use effective contraception during treatment
Serious warnings
- Risk of agranulocytosis
- Monitor for signs of infection
- Discontinue if acute pancreatitis occurs
Important Disclaimer
The Biroida 5 mg Tablet professional information leaflet below is the property of Strides Pharma Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
